ACR Meeting Abstracts
Abstract Number: 1548 • ACR/ARP Annual Meeting 2019
Carolina Merino Argumanez1, Valentina Emperiale 2, María Martín 3, Marta Valero 4, javier Bachiller 5, Beatriz Joven-Ibáñez 6, Ana Pérez-Gómez 7 and Jose Campos 1, 1Hospital Universitario Puerta de Hierro, Majadahonda (Madrid), Spain, 2Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain, 3Hospital Universitario Doce de Octubre, Madrid, Spain, 4Hospital Universitario Ramón y Cajal, Madrid, Spain, 5Rheumatology Department, Ramón y Cajal University Hospital & IRYCIS, Madrid, Spain, 6Hospital Universitario 12 de Octubre, Madrid, Spain, 7Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
Background/Purpose: Secukinumab is a newly introduced biologic therapy against IL-17 which has been proved effective in patients with ankylosing spondylitis (AS) in clinical trials and…